I'm still not seeing what could possibly result in
Post# of 30028
Posted On: 09/16/2016 4:19:54 PM
Re: Both shallow #23957
I'm still not seeing what could possibly result in an uplist. The ESS trial starting with a scheduled completion timeline of 2020?
Being bought...
GC resigns...
There is no money to fund anything, the last R/S chewed up and spit out anyone who invested prior. There is little reason to buy now unless like me you need to average down from the R/S catastrophe.
Again, I've been away from AMBS since the tanking so I haven't followed the PR's, trials or any other fundamentals. What I see with the company now is identical to what I saw post R/S except the SP isn't plummeting now.
What can cause the SP to multiply 100-125x current levels?
All I have left here is hope. I sound pessimistic due to my experience with GC and the nepotism abound at the company. If there are developments I've missed let me know and I'll own it then dye my DD.
It's the weekend, go outside and go Broncos.
Being bought...
GC resigns...
There is no money to fund anything, the last R/S chewed up and spit out anyone who invested prior. There is little reason to buy now unless like me you need to average down from the R/S catastrophe.
Again, I've been away from AMBS since the tanking so I haven't followed the PR's, trials or any other fundamentals. What I see with the company now is identical to what I saw post R/S except the SP isn't plummeting now.
What can cause the SP to multiply 100-125x current levels?
All I have left here is hope. I sound pessimistic due to my experience with GC and the nepotism abound at the company. If there are developments I've missed let me know and I'll own it then dye my DD.
It's the weekend, go outside and go Broncos.
(2)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼